H19 and cancer: A shorter OS (pooling HR = 1.19, 95% CI = 1.08 - 1.31, p = 0.0004) was observed in non-female cancer patients with higher H19 expression compared with those with lower H19 expression under a fixed-effect model (Figure 2, Supplementary Figure S3).